{
  "id": "381244462e81e161",
  "title": "Merck & Co ., Inc .: Merck Announces Positive New Data for ENFLONSIA ( clesrovimab ) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus ( RSV ) Disease Over Two RSV Seasons",
  "description": "20260219T104500Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-02/67739193-merck-co-inc-merck-announces-positive-new-data-for-enflonsia-clesrovimab-for-infants-and-children-under-2-years-of-age-at-increased-risk-for-s-004.htm",
  "published_at": "20260219T104500Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-02/67739193-merck-co-inc-merck-announces-positive-new-data-for-enflonsia-clesrovimab-for-infants-and-children-under-2-years-of-age-at-increased-risk-for-s-004.htm",
    "url_mobile": "",
    "title": "Merck & Co ., Inc .: Merck Announces Positive New Data for ENFLONSIA ( clesrovimab ) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus ( RSV ) Disease Over Two RSV Seasons",
    "seendate": "20260219T104500Z",
    "socialimage": "https://www.finanznachrichten.de/chart-merck-co-inc-aktie-intraday-tradegate.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}